What Is Cancer and How Does It Develop?

What is cancer? It is often described as uncontrolled cell division. That is true, but it leaves out much of the story. Dividing quickly is not enough to turn a normal cell into a cancer cell.

The cell must bypass several of the body’s protective systems. It must stop responding to signals that tell it to slow down, avoid cell death, alter its metabolism, and escape immune surveillance. Some cancer cells eventually acquire another dangerous ability: they can invade nearby tissues and spread to other parts of the body.

Cancer is not a single disease. The word covers hundreds of diseases that arise in different organs and from different types of cells. They vary in their mutations, growth rate, response to treatment, and many other features. What they share is a gradual loss of the controls that normally govern how a cell behaves.

Cells live by rules

The cells in our bodies do not act independently. They are constantly receiving signals from neighboring cells, the surrounding tissue, and the rest of the body. These signals tell them when to divide, when to carry out their usual function, and when to stop or die.

Without this control, tissues would quickly lose their normal structure. New cells should be produced only when old cells need replacing or damaged tissue needs repair.

When a cell’s DNA is seriously damaged, the cell may pause division and try to fix the problem. If the damage is too extensive, it can activate apoptosis, a controlled form of cell death.

There are other lines of defense as well. Specialized proteins monitor DNA and repair many of the errors that arise. The immune system can also recognize and eliminate some abnormal cells.

Trouble begins when a cell bypasses these safeguards one by one and stops following the rules that apply to normal tissue.

Where do DNA changes come from?

Before a cell divides, it must copy its DNA. The process is remarkably accurate, but biology is never completely error-free. Occasionally, copying mistakes occur. These changes are called mutations.

DNA can also be damaged by outside influences, including tobacco smoke, ultraviolet light, ionizing radiation, certain chemicals, and some infections.

A person may inherit a mutation that raises the risk of cancer. But inherited cancers account for only a fraction of all cases. Most cancer-associated changes arise during a person’s lifetime in individual cells within a particular tissue.

That is why calling cancer a genetic disease does not mean that cancer is always inherited. It means that the genetic machinery of the cancer cells has been altered.

A single random mutation is usually not enough to make a cell cancerous. Most DNA damage is repaired, and dangerously altered cells often stop dividing or die. A tumor generally develops only after several important changes accumulate in the same line of cells.

That process may take years.

Which genes are involved in cancer?

Three broad groups of genes are especially important: proto-oncogenes, tumor suppressor genes, and DNA repair genes.

Proto-oncogenes and oncogenes

Proto-oncogenes are part of normal cell biology. They transmit growth signals and help cells divide when the body actually needs new cells.

A mutation, an increase in gene copy number, or excessive activation can turn a proto-oncogene into an oncogene. The growth signal then remains active even when the tissue does not need more cells.

This is often compared to an accelerator pedal that has become stuck. The comparison is not perfect, but it captures the basic idea: the cell continues to receive a signal telling it to divide.

Tumor suppressor genes

If oncogenes act like accelerators, tumor suppressor genes act more like brakes. They restrict cell division, monitor the condition of the cell, and can trigger growth arrest or cell death when something goes wrong.

One of the best-known examples is TP53. This gene encodes the p53 protein, which responds to DNA damage and other forms of cellular stress. Depending on the situation, p53 can pause the cell cycle, allow time for repair, or help eliminate the damaged cell.

TP53 alterations are found in many cancers. Once this control mechanism is lost, a cell may continue dividing despite serious damage.

DNA repair genes

DNA repair genes encode proteins that identify and correct damage in DNA.

When one of these repair systems fails, errors begin to accumulate more quickly. That does not necessarily cause cancer immediately, but it increases the chance that additional dangerous changes will appear.

Not every mutation found in a tumor helps it grow. Changes that directly support the growth and survival of cancer cells are called driver mutations. Many others are simply passenger mutations that accumulated as the cells continued to divide.

What abilities does a cancer cell acquire?

Different cancers reach malignancy through different routes. Even so, many eventually acquire a similar set of abilities.

Cancer cells may maintain their own growth signals, ignore instructions to stop dividing, avoid programmed cell death, and continue dividing longer than normal cells.

They also face other challenges. They need energy and nutrients, must adapt to low oxygen levels, and may either use existing blood vessels or stimulate the growth of new ones.

Some tumors learn to suppress the immune response. At later stages, certain cells gain the ability to invade nearby tissues and form metastases.

These abilities rarely appear all at once. A tumor develops gradually. New cell variants keep appearing within it, and those that grow or survive more effectively gain an advantage.

Cancer is not only about mutations

The DNA sequence matters, but it does not determine a cell’s behavior on its own. It also matters which genes are active, which are silent, and how strongly they are expressed.

These patterns are controlled in part by epigenetic mechanisms. They include DNA methylation, histone modifications, and changes in chromatin structure.

In cancer, this regulation can become distorted. A tumor suppressor gene, for example, may remain physically intact but become epigenetically silenced. In another case, an altered gene-expression program may help the cell divide, survive, or change its properties.

Modern cancer biology therefore cannot be reduced to the search for mutations alone. Tumor development involves both genetic alterations and epigenetic reprogramming.

A cell can lose its specialization

Most cells in the body perform a clearly defined job. A liver cell differs from a skin cell not because it contains a completely different set of genes, but because it uses a different part of the genome.

During cancer development, that specialization may begin to break down.

Some cells return to a less mature state resembling a progenitor cell. In others, normal maturation becomes blocked. A tumor cell may even switch part of its identity and begin using a program normally associated with another cell type.

This ability to change state is called phenotypic plasticity.

Plasticity can help a tumor adapt to new conditions. A cell may become more mobile, survive treatment, or enter a state in which a particular drug is less effective.

A tumor is more than a mass of cancer cells

A tumor contains much more than malignant cells. It also includes blood vessels, fibroblasts, immune cells, extracellular matrix, and many signaling molecules.

Together, these components form the tumor microenvironment.

Cancer cells interact constantly with the cells around them. They may stimulate blood-vessel growth, alter the behavior of fibroblasts, or weaken the antitumor immune response.

Some immune cells continue to attack the tumor. Others, after being exposed to signals from the surrounding tissue, may begin to support inflammation, blood-vessel growth, or tissue repair—processes that the tumor can exploit.

The microenvironment can also influence treatment. The same drug may destroy cells efficiently in one part of a tumor but penetrate poorly or work less effectively in another.

A tumor is therefore not simply a lump of rapidly dividing cells. It is a changing biological ecosystem.

Why are the cells within one tumor different?

A tumor often begins with one altered cell or a small group of related cells. As they divide, they form a clone.

But DNA copying continues, and new changes arise in daughter cells. Some have no meaningful effect. Others provide an advantage by accelerating growth, improving survival under low-oxygen conditions, helping the cell escape immune attack, or allowing it to withstand a drug.

Over time, several cell populations emerge within the same tumor. They may differ in their mutations, epigenetic states, metabolism, and sensitivity to treatment.

This is a form of evolution taking place inside one person. Conditions within the tissue, as well as treatment itself, create selective pressure. The cells best suited to the current environment are the ones most likely to survive and multiply.

That is why a tumor can change over time. Treatment may eliminate sensitive cells while resistant variants survive and eventually resume growth.

What is the difference between a benign and a malignant tumor?

A benign tumor can also arise from cells that are multiplying more than they should. In most cases, however, it remains confined to its site of origin, does not invade neighboring tissues, and does not form metastases.

That does not make every benign tumor harmless. Even a nonaggressive growth can compress vital structures, disrupt the function of an organ, or produce excessive amounts of hormones.

Malignant tumors behave differently. Their cells can break through normal tissue boundaries, invade surrounding structures, and spread through the body.

Not every cancer forms a solid mass. In leukemia, for example, malignant cells arise in the blood-forming system and accumulate in the bone marrow and bloodstream.

How do metastases form?

Metastasis is a difficult and inefficient process. Most cells that leave the original tumor do not survive.

To form a metastasis, a cancer cell must separate from its neighbors, enter a blood or lymphatic vessel, and survive the journey through the body. It must then leave the vessel, establish itself in a new tissue, and begin dividing again.

Each stage presents a separate obstacle. But if even one cell completes the entire journey and creates a new tumor deposit, a metastasis has formed.

The metastatic tumor retains the identity of the original cancer. If breast cancer cells are found in the lung, the disease is still breast cancer—specifically, metastatic breast cancer. It does not become lung cancer.

Why does cancer behave differently in different people?

Even cancers that arise in the same organ can be very different.

Two people with lung cancer or breast cancer may have different driver mutations, different patterns of gene activity, and different immune-cell populations in the tumor microenvironment. One tumor may grow quickly but respond well to treatment. Another may develop more slowly yet be resistant to a particular drug from the start.

The name of the affected organ is therefore no longer enough to describe the disease fully.

Doctors also consider what the cells look like under the microscope, the stage of the disease, the molecular subtype, and the presence of particular biomarkers. Some alterations suggest that a tumor may respond to a targeted drug. Others warn that resistance is more likely.

These differences form the basis of modern molecular oncology.

The main point

Cancer almost never begins with a single event. A cell usually accumulates genetic and epigenetic changes step by step and gradually escapes the control of the body.

It learns to sustain its own growth, avoid cell death, alter its metabolism, use the surrounding tissue, and evade the immune system. Some tumors also acquire the ability to invade nearby tissues and form metastases.

But one mutation, one risk factor, or one abnormal cell does not mean that cancer will inevitably develop. Many biological barriers stand between the first cellular alteration and a clinically detectable disease.

By studying each of these stages, researchers can identify weaknesses in the tumor. This knowledge underlies cancer prevention, early detection, targeted therapy, and many other modern approaches to treatment.